First Ever Clinical Trial for Cannabis Migraine Treatment is Underway

Veriheal

However, there has not been a clinical trial assessing the efficacy of cannabis for migraines, at least not until now. Science Alert has announced that the first clinical trial for cannabis as a migraine treatment is underway.

Clinical Trial: Cannabis Inhalation Associated with Clinical in Patients with Ulcerative Colitis

NORML

“This study demonstrates that treatment with THC-rich cannabis in patients with mild to moderate UC is associated with clinical improvement.". The post Clinical Trial: Cannabis Inhalation Associated with Clinical in Patients with Ulcerative Colitis appeared first on NORML.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clinical Trial: Whole-Plant Cannabis Extracts Associated with Improved Outcomes in Autistic Patients

NORML

“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".

Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects

NORML

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care.

CBG is safe, gets green light for clinical trials and therapy

Cannabis Life Network

Even as a common name, CBG had yet to undergo the same tests and clinical trials as CBD to ensure high doses are safe. The post CBG is safe, gets green light for clinical trials and therapy appeared first on Latest Cannabis News Today - Headlines, Videos & Stocks.

Clinical Trial: Plant-Derived Cannabis Oil Effective for Patients with Fibromyalgia

NORML

The post Clinical Trial: Plant-Derived Cannabis Oil Effective for Patients with Fibromyalgia appeared first on NORML. "We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement in these patients.".

MindMed’s Mescaline Study Approved For Clinical Trial

Cannabis Law Report

MindMed (Nasdaq: MNMD) announced today that its clinical trial plans to evaluate the acute effects of serotonergic hallucinogen mescaline have… Read More.

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Numinus Announces Clinical Trial Of Psilocybin-Assisted Psychotherapy

Cannabis Life Network

announced early this morning that it will undertake a clinical trial of psilocybin-assisted psychotherapy. About the Research & Clinical Trial Numinus Wellness […]. Vancouver based Numinus Wellness Inc.

House Passes Bipartisan Bill Facilitating Clinical Cannabis Research, Allowing Scientists to Access State-Approved Marijuana Products

NORML

The post House Passes Bipartisan Bill Facilitating Clinical Cannabis Research, Allowing Scientists to Access State-Approved Marijuana Products appeared first on NORML. LEGISLATION Research SCIENCE clinical trials DEA House vote research University of Mississippi

Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials

Cannabis Law Report

NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally.

Psychedelic Clinical Trials & Who’s Behind Them

Cannabis Law Report

The post Psychedelic Clinical Trials & Who’s Behind Them first appeared on Cannabis Law Report. CFN report… The psychedelics industry has experienced unprecedented growth over the past few years, driven by a combination of emerging… Read More.

Tryp Therapeutics Announces Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Cannabis Law Report

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The Principal Investigator for the trial will be Kevin Boehnke, Ph.D.,

MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine

Cannabis Law Report

Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc.

FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial

Cannabis Law Report

Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19.

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. POTOMAC, Md.–(BUSINESS

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin.

Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

Cannabis Law Report

Partnership Aimed at Delivering Psychedelic Capsule for Dosing Study in Human Clinical Trial. VANCOUVER, BC, May 11, 2021 /CNW/… Read More. Cannabis Finance News

NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials

Cannabis Law Report

The post NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials first appeared on Cannabis Law Report. We hope he does a better job than some of the playlists we’ve seen recently ! NeonMind Biosciences Inc. … Read More.

UK: Imperial College Of London To Study DMT In First-Ever Clinical Trial

Cannabis Law Report

Clinical trials on the hallucinogenic drug DMT for the treatment of depression are expected to start in January. The post UK: Imperial College Of London To Study DMT In First-Ever Clinical Trial first appeared on Cannabis Law Report. Yahoo Finance Reports.

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

Ehave, Inc. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board.

Cannabis Law Report

As a member of Ehave’s Medical Advisory Board, Dr. Desai’s main responsibilities will be to assist and advise the Company on human trials for its cognitive and psychedelic opportunities, as well as assist and advise the Company on mental health analytical platforms.

Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.

Cannabis Law Report

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Extensive early phase experience with appropriate safety oversight and early phase clinic.

Clinical Trial: Transdermal Application of CBD Effective in Patients with Myofascial Pain

NORML

The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine. Polish investigators conducted a randomized, double-blind placebo-controlled trial assessing the efficacy of twice-daily transdermal CBD administration on 60 patients with TMD over a period of 14 days.

MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan

Cannabis Law Report

Key objective of the trial is to reduce levels of the protein that causes inflammation and activates aging, TNF-?, The primary goal of this Phase 2 double-blind, placebo-controlled clinical trial is to achieve a reduction in the levels of tumor necrosis factor-alpha (TNF-?)

Japanese Officials Approve Epidiolex For Clinical Trials

Cannabis Law Report

The trials, to be tightly controlled in a hospital environment, are exempted from Japan’s Cannabis Control Act, which bans cannabis compounds generally. Ministry of Health, Labor and Welfare officials recently announced the trials during a meeting of the Okinawa-Northern Task Force, a research and development agency. Japanese officials approve Epidiolex for clinical trials.

Final Phase of MDMA Clinical Trials Shows Drug Is 90% Effective at Treating PTSD

SpeedWeed

A first-of-its-kind Phase 3 clinical trial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. Image via.

Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines

Cannabis Law Report

– Vaccine Candidate Well Tolerated and Effective in Cohort – – Strong Neutralizing Antibody Titer Elicited Across Cohort – STONY… Read More. Business Wire

Treating addictions with psychedelic psychotherapy

Cannabis Life Network

Imagine having a treatment-resistant addition. You’ve tried going to therapy, taking medications, receiving treatment at rehabilitation centres–everything. But none of it worked. Where do you even go from there? What else is there to do?

Clinical Trial Shows Association Between Cannabis Inhalation and Improvement in Ulcerative Colitis

SpeedWeed

The trial , titled “Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial,” was published in the PLoS One journal and outlines the effects of high-THC cannabis use on ulcerative colitis.

ANANDA Scientific and David Geffen School of Medicine UCLA Announce Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD)

Cannabis Law Report

Food and Drug Administration (FDA) for this trial. Pre-clinical and initial clinical studies show that ANANDA’s Liquid Structure technology (licensed from Lyotropic Delivery Systems (LDS) Ltd. This trial is being led by principal investigators Edythe London, Ph.D.,

InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

Puff Puff Post

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs.

Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx(TM)

Cannabis Law Report

Results expected to support the Company’s plans to file an IND application with the FDA for a Phase II international… Read More. Cannabis Finance News

Clinical Trial Finds Marijuana Oil to be Effective in Treating Fibromyalgia

The Joint Blog

The study concludes by stating that “To our knowledge, this is the first randomized controlled trial to demonstrate the benefit of cannabis oil – a THC-rich whole plant extract – on symptoms and on [the] quality of life of people with fibromyalgia.

InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial

Puff Puff Post

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. ” “This is a significant milestone for the Company as we transition from a preclinical to a clinical stage organization,” says Eric A.

FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials

Otherside Farms

Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. Our definition of pure is no THC,” Guy said, adding that clinical study would help provide “better understanding and experience in what cannabidiol does in these different children groups, what benefit we can see, and how the results can best be measured.”.

Are Marijuana Inhalers Most Effective Treatment For Chronic Pain?

The Fresh Toast

Cannabis Medical Marijuana News RX cannabis inhalers chronic pain clinical trials Neuropathy THCAre Marijuana Inhalers Most Effective Treatment For Chronic Pain?